MacroGenics Inc (MGNX)

NASDAQ
26.41
+1.30(+5.18%)
After Hours
25.87
-0.54(-2.04%)
- Real-time Data
  • Volume:
    630,427
  • Bid/Ask:
    24.50/27.19
  • Day's Range:
    25.08 - 26.84

MGNX Overview

Prev. Close
26.41
Day's Range
25.08-26.84
Revenue
108.08M
Open
25.46
52 wk Range
18.16-36.48
EPS
-2.53
Volume
630,427
Market Cap
1.59B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
787,177
P/E Ratio
-
Beta
2.23
1-Year Change
2.44%
Shares Outstanding
60,036,407
Next Earnings Date
Jul 29, 2021
What is your sentiment on MacroGenics Inc?
or
Market is currently closed. Voting is open during market hours.

MacroGenics Inc News

MacroGenics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyBuyBuy
Technical IndicatorsNeutralStrong BuyStrong BuyBuyStrong Buy
SummaryNeutralStrong BuyStrong BuyBuyStrong Buy

MacroGenics Inc Company Profile

MacroGenics Inc Company Profile

Employees
370

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology platforms and also in collaboration with other biopharmaceutical companies. It has a pipeline of product candidates in human clinical testing, primarily as treatments for different types of cancers, which are created using its technology platforms. Its clinical product candidate, margetuximab, has been enhanced using its Fc Optimization platform. The Company is also developing several product candidates targeting B7-H3, a protein in the B7 family of immune regulator proteins. The Company's product candidates also include enoblituzumab and MGD009, MGC018, MGD006 (flotetuzumab), MGD007, MGD011 (duvortuxizumab), PF-06671008 and MGD010.

Read More
  • Fda approved mgnx for breast cancer treatment today, deff buying it tom !!
    0
    • You can buy it now why wait till tomorrow ?
      0
  • why a drastic fall ?
    0
    • why is this still in its 20s?
      0
      • any news on MGNX ? why such as drastic crash ?
        0
        • No FDA approval it's going to drop like rock!
          0
          • so buy or dont ?
            2
            • this company is pretty good the more I look at them.  could be a good buy out from a larger company.  If it gets sold this thing will sky rocket.  Shorting for now but will keep an eye on it after I cover
              0
              • added to watch list - but will crashhhhh on Friday
                0
                • interesting stock...getting a bump in AH trading..still shorting the ******out of it though
                  0
                  • Stair stepping Down........Watch out for that last step!!! Holy Moly 🙀
                    0
                    • Not much holding this up, going to drop heavy
                      0
                      • Inevitable drop to $10-13 No question it doesn't stay up here
                        0
                        • Still shorting, wait until people actually flow into this name. Will be back to $13
                          0
                          • You keep shorting they will keep squeezing you lol
                            0
                        • If you're buying this junk at these ridiculous prices you have no business trading, period!
                          0
                          • Big L for the guy of yesterday
                            0
                            • Till FDA approval, its not going up again. (((
                              0
                              • cash out, im done
                                0
                                • SHORTY SHORTY
                                  0
                                  • Is it going to go up today ?
                                    0
                                    • the pump today was really unwarranted given the expenses on the ER lol.. analysts downgraded it rightfully below $15. Pump and dump here - simple as that
                                      0
                                      • Analyst sets MacroGenics Inc. (MGNX) 12-month price target of $50.00. keep buying and hold near $50. lets all double our money
                                        1
                                        • Analyst sets MacroGenics Inc. (MGNX) 12-month price target of $50.00 buy buy buy https://weeklyoracle.com/2020/05/06/analyst-sets-macrogenics-inc-mgnx-12-month-price-target-of-50-00-is-it-realistic/
                                          0
                                          • this is a locura total.
                                            0
                                            • why is this up ???
                                              0
                                              • https://www.fool.com/investing/2020/05/06/heres-why-macrogenics-stock-is-skyrocketing-171-to.aspx
                                                0
                                            • for intraday it will hit at least 23.9 for shorting
                                              2
                                              • how did that work out for you?
                                                0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.